• 20-year partnership agreement expected to generate a EUR 20 million upfront milestone, as well as annual recurring revenues for the duration of the contract
  • Deal forms part of Mithra’s strategy to realise the full potential of the pipeline programs through global partnerships with leaders in Women’s Health

Liège, Belgium, 26 September 2017 – Mithra (Euronext Brussels: MITRA), a company specialized in Women’s Health, is pleased to announce that it has signed a binding Head of Terms agreement with Libbs, the Women’s Health leader in Brazil, for an exclusive license to commercialize Estelle®, Mithra’s novel combined oral contraceptive (COC) product candidate, in Brazil.

Liège, Belgium, 21 September 2017 – Mithra (Euronext Brussels: MITRA), a company specialized in women’s health, today announces its financial results for the six-month period ending 30 June 2017, prepared in accordance with IFRS. The full interim report is available on the website in the Investors section (investors.mithra.com).

Read the press release
Read the half year report